Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...

That “something” was HIV, the human immunodeficiency virus, which attacks the body’s immune system. Aoife was advised she ...

The regional director of UNAIDS Asia Pacific Eamonn Murphy said rising new infections in Fiji "put the entire Pacific region ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...